Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

• Status: Recruiting
• Trial end date: 2023-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to perform a randomized trial to investigate if intrapartum insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous insulin infusion with regard to the primary outcome of neonatal blood sugar.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gianna Wilkie
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Pregnant women with pre-gestational diagnosis of type 1 diabetes mellitus and managed on an insulin pump in pregnancy

• Pregnancy and delivery care obtained at University of Massachusetts (UMass) Memorial Medical Center

• Patients able to provide written informed consent

Exclusion Criteria:

• Patients who are under the age of 18

• Patients with altered state of consciousness

• Critically ill patient requiring intensive care unit admission

• Patient at risk for suicide

• Patient refuses or is otherwise unable to participate in own care

• Patient without pump supplies

• Patients presenting with diabetic ketoacidosis on admission